Shay Capital LLC My Md Pharmaceuticals, Inc. Transaction History

Shay Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.92 - $96.0 $61,869 - $6.46 Million	67,249 Added 48.04%	207,235 $238,000
Q3 2022 Nov 14, 2022	SELL	$2.22 - $82.2 $375,606 - $13.9 Million	-169,192 Reduced 54.72%	139,986 $365,000
Q2 2022 Aug 15, 2022	SELL	$2.0 - $4.78 $24,018 - $57,403	-12,009 Reduced 3.74%	309,178 $671,000
Q1 2022 May 16, 2022	SELL	$3.34 - $6.05 $122,254 - $221,448	-36,603 Reduced 10.23%	321,187 $1.5 Million
Q4 2021 Feb 14, 2022	BUY	$5.46 - $9.69 $876,908 - $1.56 Million	160,606 Added 81.45%	357,790 $2.17 Million
Q3 2021 Nov 15, 2021	SELL	$4.64 - $7.94 $1.69 Million - $2.9 Million	-365,016 Reduced 64.93%	197,184 $1.42 Million
Q2 2021 Aug 13, 2021	BUY	$3.39 - $6.98 $1.91 Million - $3.92 Million	562,200 New	562,200 $3.54 Million

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Shay Capital LLC with notifications on news.